Drug Discovery & Development | Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies DailyFinance Seattle Genetics is best known for its one successful marketed cancer drug, but it has been busy working behind the scenes for years on new technologies for making souped-up antibodies against cancer. Now AbbVie has agreed to pay $25 million to gain ... Seattle Gentics-AbbVie Deal Expanded Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with ... Seattle Genetics and AbbVie Broaden Partnership |
